One day in May two
years ago, Ms. Fan suddenly developed a strange symptom. She had intermittent
numbness in her upper and lower limbs, especially in her calf symptoms. There
were no cerebrovascular disease, hemiplegia, headache, or dizziness. The
symptoms occurred about twenty or thirty times a day, and the duration of these
varied, sometimes two or three minutes, and sometimes one minute. In addition,
the symptoms were accompanied by pain.
Fan was examined at a local hospital and
diagnosed with optic neuromyelitis. After half a month in hospital, her
symptoms did not improve significantly. Her upper and lower limbs were still as
numb as before and tended to get worse.
On July 10, 2017, Ms.
Fan came to Hebei Yiling hospital for consultation. After detailed
examinations, experts from the Department I of Rheumatology and immunology of
the hospital learned that in the past two years, Ms. fan had experienced two or
three times of sudden blindness, which were alleviated to some extent through
treatment. At present, her vision was only 0.1, and she can see the road
clearly but still had some ambiguity. The most important was the intermittent
numbness attack of upper and lower limbs, which was very uncomfortable.
Experts from
rheumatology and Immunology Department I of Hebei Yiling hospital made a
personalized treatment plan for her. After a month's treatment, Ms. fan had
only two or three attacks a day, and the degree of pain was significantly
reduced. The most obvious trouble of the lower limbs was gone, but the upper
limbs were still numb.
Fubin Jiang, a
director of the first rheumatic Immunology Department, said that optic
neuromyelitis is an idiopathic inflammatory demyelinating disease of the
central nervous system, which is mainly confined to the spinal cord and optic
nerve. It is an autoimmune disease mediated by autoantibodies, with an
incidence of 1/100,000 in Europe and the United States, and a relatively high
incidence in Asia. If treatment is delayed or improperly treated, 80% of them
will develop horizontal myelitis, leading to lifelong paralysis or death.
In order to reduce
disease attack, relieve pain, prolong life and improve quality of life,
rheumatology and Immunology experts of Hebei Yiling hospital summed up a set of
"early systematic comprehensive foot therapy program through strengthening
method" in the long-term diagnosis and treatment practice, to help many
patients with optic neuritis get lasting stability and relief. According to
reports, the early stage refers to the time when the disease has not occurred
irreversibly and the standard intervention can be controlled; the foot
treatment process refers to the sufficient dose and long course of treatment.
Patients should not stop taking medication when their condition improves,
otherwise it will relapse again. Each relapse of the disease will increase the
difficulty of treatment, so it is necessary to adhere to the foot treatment
process according to the condition, constitution, etc. Sequential refers to the
dynamic adjustment of the diagnosis and treatment plan, that is, the
implementation of the optimized and personalized dynamic diagnosis and
treatment plan under the guiding principles of diagnosis and treatment. Regular
strengthening means a comprehensive clinical evaluation of different diseases
at different stages according to the severity of the disease, physical fitness
and response to drugs, and then decide whether to strengthen the treatment.
Up to now, two years
have passed. On the second anniversary of the visit, we learned that Ms. Fan's
daily life is normal in all aspects, and the lingering strange disease of
numbness in her arms and legs has not appeared for two years. As director Jiang
said, it has achieved long-term stability without recurrence. Their whole
family were very satisfied and admired the treatment technology of Yiling
hospital.
|